MedTrace Logo

Effects of Xal-Ease on Patient Compliance With Xalatan

NCT00573638 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2008-08-08

No results posted yet for this study

Summary

The study hypothesis is that the Xal-Ease with increase patient compliance with XALATAN

Conditions

Interventions

DEVICE

Xal-Ease device to be used with Xalatan eye drops

This intervention is a drop instillation guide to be used in conjunction with the FDA approved Xalatan eye drop.

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Augusta University

    lead OTHER

Principal Investigators

  • Christian D. Nilson, MD · Augusta University

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-02-28
Completion
2009-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00573638 on ClinicalTrials.gov